Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Vera Therapeutics Inc shares valued at $730,535 were sold by Fordyce Marshall on Jan 08 ’25. At $41.74 per share, Fordyce Marshall sold 17,500 shares. The insider’s holdings dropped to 143,603 shares worth approximately $4.85 million following the completion of this transaction.
Also, MARSHALL FORDYCE purchased 17,500 shares, netting a total of over 736,750 in proceeds.
Before that, Fordyce Marshall had sold 17,500 shares from its account. In a trade valued at $753,680, the PRESIDENT AND CEO traded Vera Therapeutics Inc shares for $43.07 each. Upon closing the transaction, the insider’s holdings decreased to 17,500 shares, worth approximately $2.9 million.
As published in their initiating research note from Wells Fargo on November 21, 2024, Vera Therapeutics Inc [VERA] has been an Overweight and the price target has been revised to $70. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. As of January 25, 2024, Oppenheimer has initiated its “an Outperform” rating for VERA. Earlier on January 08, 2024, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for VERA stock.
Analyzing VERA Stock Performance
During the last five days, there has been a drop of approximately -2.37%. Over the course of the year, Vera Therapeutics Inc shares have dropped approximately -20.15%. Shares of the company reached a 52-week high of $43.76 on 01/06/25 and a 52-week low of $31.77 on 01/13/25. A 50-day SMA is recorded $43.83, while a 200-day SMA reached $40.43. Nevertheless, trading volume fell to 0.61 million shares from 1.02 million shares the previous day.
Support And Resistance Levels for Vera Therapeutics Inc (VERA)
According to the 24-hour chart, there is a support level at 33.21, which, if violated, would cause prices to drop to 32.66. In the upper region, resistance lies at 34.21. The next price resistance is at 34.66. RSI (Relative Strength Index) is 24.98 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.11, which suggests the price will decrease in the coming days. Percent R is at 83.32%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
